Vets at Massachusetts Veterinary Referral Hospital describe how LexaGene’s beta prototype has excited them and given them a view of the future: rapid, in-clinic diagnostics that improve confidence in diagnosis, clinic workflow and patient outcome.
See how rapid, point-of-care molecular diagnostics could have improved patient outcome. Read the story of how Nancy the Dachshund did not receive the correct treatment due to the lag-time to receive lab results, and how LexaGene’s LX6 could have prevented this scenario.
LexaGene describes the technology behind our fully automated, open-access pathogen detection device, the LX Analyzer.
